| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/02/2004 | EP1372642A1 Use of pyrazolopyridines as therapeutic compounds |
| 01/02/2004 | EP1372641A1 Enteral formulation |
| 01/02/2004 | EP1372640A2 Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of cns disorders and a process for the preparation thereof |
| 01/02/2004 | EP1372639A2 Agent for the treatment of bladder irritative symptoms accompanied by benign prostatic hyperplasia |
| 01/02/2004 | EP1372638A1 Functional role for cannabinoids in autonomic stability during sleep |
| 01/02/2004 | EP1372637A2 Premixed amiodarone parenteral solution and method for making the same |
| 01/02/2004 | EP1372636A2 Metronomic dosing of taxanes for inhibiting tumor growth |
| 01/02/2004 | EP1372635A1 Use of creatine for the amelioration of oxidative stress |
| 01/02/2004 | EP1372634A2 Fumaric acid amides |
| 01/02/2004 | EP1372633A1 Irrigating fluid |
| 01/02/2004 | EP1372632A1 Proliferative activator receptor (ppar) compounds |
| 01/02/2004 | EP1372631A1 Method and formula for anti-tumor and anti-matastatic effect |
| 01/02/2004 | EP1372630A2 Agent for the treatment of overactive bladder |
| 01/02/2004 | EP1372629A2 Therapeutic treatment |
| 01/02/2004 | EP1372628A2 Paracetamol solutions which are stable in storage and ready for infusion |
| 01/02/2004 | EP1372627A1 Use of breakers of advanced glycation endproducts for treating deleterious effects of aging and debilitating diseases |
| 01/02/2004 | EP1372625A1 Uses of benzylideneamino guanidines as ligands to the melanocortiin receptors |
| 01/02/2004 | EP1372624A2 Tramadol-based medicament |
| 01/02/2004 | EP1372622A1 Parasiticidal compositions and methods of use |
| 01/02/2004 | EP1372621A1 Novel use of tyrosine kinase inhibitor |
| 01/02/2004 | EP1372620A2 Methods for restoring cognitive function following systemic stress |
| 01/02/2004 | EP1372619A2 Highly flexible transdermal therapeutic system having nicotine as active substance |
| 01/02/2004 | EP1372618A1 Colloidal suspension of nanoparticles based on an amphiphilic copolymer |
| 01/02/2004 | EP1372617A2 Enteric ketoacid salts and amino acids and their use for preparing medicines |
| 01/02/2004 | EP1372616A2 A stable pharmaceutical composition of pravastatin |
| 01/02/2004 | EP1372615A1 Compounds and compositions for delivering active agents |
| 01/02/2004 | EP1372614A1 Controlled release sulfonylurea formulation |
| 01/02/2004 | EP1372611A2 Pharmaceutical composition comprising a poorly water-soluble active ingredient, a surfactant and a water-soluble polymer |
| 01/02/2004 | EP1372610A2 Powder inhaler formulations |
| 01/02/2004 | EP1372608A1 Medical aerosol formulations |
| 01/02/2004 | EP1372605A2 Intravaginal drug delivery devices for the administration of an antimicrobial agent |
| 01/02/2004 | EP1372603A1 Topical application for treating toenail fungus |
| 01/02/2004 | EP1372600A2 Skin care compositions containing a sugar amine |
| 01/02/2004 | EP1372597A1 Metronidazole pledgets |
| 01/02/2004 | EP1372595A2 Photoprotecting formulations |
| 01/02/2004 | EP1372571A2 Method and compositions for optimizing blood and tissue stability of camptothecin and other albumin-binding therapeutic compounds |
| 01/02/2004 | EP1372551A2 Facially amphiphilic polymers as anti-infective agents |
| 01/02/2004 | EP1372413A2 Increasing phosphorus uptake from the gut of dairy cows by supplementing with 1-alpha-hydroxylated vitamin d |
| 01/02/2004 | EP1372412A2 Composition improving age-related physiological deficits and increasing longevity |
| 01/02/2004 | EP1372411A1 Low glycemic response compositions |
| 01/02/2004 | EP1372394A1 Antifungal composition with enhanced bioavailability |
| 01/02/2004 | EP1372392A1 Nicotine-containing oral dosage form |
| 01/02/2004 | EP1372389A2 Virucidal compositions |
| 01/02/2004 | EP1372383A2 Antimicrobial formulations |
| 01/02/2004 | EP1235830B1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS AS PROTEIN KINASES INHIBITORS |
| 01/02/2004 | EP1228031B1 Omega chain modified 15-hydroxyeicosatetraenoic acid derivatives useful for the treatment of dry eye |
| 01/02/2004 | EP1228026B1 15-hydroxyeicosatetraenoic acid-related compounds and methods of use |
| 01/02/2004 | EP1203011B1 Orally active androgens |
| 01/02/2004 | EP1083874B1 Use of a compound for the preparation of a medicament for treating alopecia or promoting hair growth in an animal |
| 01/02/2004 | EP1044187B1 N-benzyl-3-indenylacetamides derivatives for treating neoplasia |
| 01/02/2004 | EP1036062B1 Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors |
| 01/02/2004 | EP1027339B1 Method and reagents for n-alkylating ureides |
| 01/02/2004 | EP0986570B9 Gemcitabine derivatives |
| 01/02/2004 | EP0979103B1 Light imaging contrast agents |
| 01/02/2004 | EP0746343B1 Bioartificial kidney devices coated with cells suitable for use in vivo or ex vivo |
| 01/02/2004 | EP0719343B1 Adeno-associated viral (aav) liposomes and methods related thereto |
| 01/02/2004 | EP0663008B1 Improvements in or relating to immune response modification |
| 01/01/2004 | US20040003421 Lysosomal proteins produced in the milk of transgenic animals |
| 01/01/2004 | US20040003418 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer |
| 01/01/2004 | US20040002647 Gel injection treatment of body parts |
| 01/01/2004 | US20040002613 Synthesis of benzonitriles from substituted benzoic acid |
| 01/01/2004 | US20040002608 Central nervous system disorders |
| 01/01/2004 | US20040002604 Phenylalkynes |
| 01/01/2004 | US20040002602 Synthetic process for the manufacture of an ecteinaschidin compound |
| 01/01/2004 | US20040002596 1,2,4-triazole triazole nucleosides; used to treat an infection, an infestation, a neoplasm, or an autoimmune disease |
| 01/01/2004 | US20040002584 Proteins, polynucleotides encoding them and methods of using the same |
| 01/01/2004 | US20040002549 Optically active fluorinated vasoconstrictors, methods for making them, and anesthetic formulations comprising them |
| 01/01/2004 | US20040002548 Therapy for respiratory system disorders |
| 01/01/2004 | US20040002546 Bupropion hydrochloride; autoimmune disease, antiinflammatory agents |
| 01/01/2004 | US20040002545 For plants |
| 01/01/2004 | US20040002544 Antidiabetic preparation for oral administration |
| 01/01/2004 | US20040002543 Synergistic mixture |
| 01/01/2004 | US20040002541 Muscular disorders; therapy for multiple sclerosis |
| 01/01/2004 | US20040002540 Method for increasing the concentration of ascorbic acid in brain tissues of a subject |
| 01/01/2004 | US20040002539 Enzyme inhibitors; anticoagulants; blood collecting device |
| 01/01/2004 | US20040002537 Multiple sclerosis; central nervous system disorders; side effect reduction |
| 01/01/2004 | US20040002536 Composition of melatonin for induction of general anesthesia |
| 01/01/2004 | US20040002535 Methods of treating hormone-related conditions using thio-oxindole derivatives |
| 01/01/2004 | US20040002534 Stem cell factor; signal transduction passageways; anticancer agents |
| 01/01/2004 | US20040002533 Culture product of Streptomyces; lanosterol synthase inhibitor; anticholesterol agents, fungicides |
| 01/01/2004 | US20040002530 Composition for the prevention and/or treatment in newborn babies of the effects of complications during childbirth |
| 01/01/2004 | US20040002529 Mixture with diuretics; hypotensive agents |
| 01/01/2004 | US20040002528 CBI analogs of CC-1065 and the duocarmycins |
| 01/01/2004 | US20040002526 Phospholipase D inhibitors and uses thereof |
| 01/01/2004 | US20040002525 Obesity; osteoporosis |
| 01/01/2004 | US20040002524 Cardiovascular disorders; osteoporosis; central nervous system disorders |
| 01/01/2004 | US20040002523 Aryl substituted pyrazoles, triazoles and tetrazoles, and the use thereof |
| 01/01/2004 | US20040002522 Antiinflammatory agents; analgesics |
| 01/01/2004 | US20040002521 Antiinflammatory agents; metalloprotease inhibitor; antiarthritic agents; antiallergens; viricides |
| 01/01/2004 | US20040002520 Applying mixture to oral cavity a solution of nicotine and water |
| 01/01/2004 | US20040002519 Mixture of hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, insulin elimination promoter and insulin sensitizer with carrier |
| 01/01/2004 | US20040002518 Anticancer agents; tyrosine kinase inhibitor; wound healing agents |
| 01/01/2004 | US20040002517 Alzheimer's disease |
| 01/01/2004 | US20040002516 Use of R (+)-alpha-(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol for the treatment of sleep disorders |
| 01/01/2004 | US20040002514 Blocking leukotrienes; skin disorders |
| 01/01/2004 | US20040002512 Alpha-substituted carboxylic acid derivatives |
| 01/01/2004 | US20040002511 Novel pyrazolo[1,5-a]pyridine derivatives and their use as neurotransmitter modulators |
| 01/01/2004 | US20040002510 Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament |
| 01/01/2004 | US20040002508 Antitumor agents; anticancer agents; sexual disorders; cardiovascular disorders |
| 01/01/2004 | US20040002507 Rho-kinase inhibitors |